CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
A legfontosabb adatok
- Hol
- Waltham (Egyesült Államok)A helyszín megnézése
Helyszínek itt: Egyesült Államok
- CorEvitas, LLCWaltham, Egyesült ÁllamokContact: Jeffrey GreenbergRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- CorEvitas
- Azonosító
- NCT05745389
- A regiszteradat frissítve
- 2026. február 9.
- Eredeti leírás
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.A teljes eredeti leírásKevesebb
Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Bevonási feltételek: A subject must meet all the following criteria to participate in the registry:; Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner; Is at least 18 years of age or older; Is willing to provide Personal Information; Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment.
Kizáró feltételek: Any of the following would exclude the subject from participating in the registry:; Is participating or planning to participate in a double-blind randomized trial for an AA drug. Note:; Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.